NASDAQ:OTLK

Outlook Therapeutics Stock Predictions

etoro logo Buy OTLK
*Your capital is at risk
$0.81
-0.0038 (-0.467%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

OTLK Prediction Chart

OTLK Predictions History

Latest community submissions for OTLK.
Predictor Target Session Target Price Result Direction Accuracy Score
Jun 2, 2025 $1.78 -3.13% $1.77 V 99.30% 4
Jun 2, 2025 $1.80 -1.95% $1.77 V 98.08% 1
Jun 2, 2025 $2.00 +8.70% $1.77 X 87.01% 0
May 29, 2025 $1.81 +11.04% $1.80 V 99.44% 4
May 27, 2025 $1.66 +3.64% $1.61 V 97.01% 1
May 27, 2025 $1.64 +2.27% $1.61 V 98.36% 1
May 27, 2025 $1.80 +12.50% $1.61 V 88.20% 1
May 22, 2025 $1.85 +13.50% $1.64 V 87.20% 1
May 19, 2025 $1.81 +3.26% $1.76 V 97.33% 1
May 19, 2025 $1.71 -2.04% $1.76 X 97.41% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for OTLK with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT OUTLOOK THERAPEUTICS INC.
Outlook Therapeutics
Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration and lice...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE